Abstract
To assess the role of neutrophils and arachidonate metabolites in evolving myocardial infarction, the effect of inhibitors of arachidonate metabolism on the extent of myocardial damage and neutrophil function was examined in a 90-minute occlusion/5-hour reperfusion model of canine myocardial infarction. A thromboxane A2 synthetase inhibitor, CV-4151, and a lipoxygenase inhibitor, AA-861, greatly reduced the infarct size. They also attenuated the production of chemoattractant leukotriene B4 and chemotactic activity of neutrophils isolated from peripheral circulation. Under these conditions, both the increases in peripheral leukocyte count and neutrophil infiltration in ischemic myocardium were inhibited. These results indicate that the inhibition of 2 pathways of arachidonate metabolism may decrease infiltration of activated neutrophils in ischemic myocardium by attenuating chemotactic function of neutrophils, resulting in reduction of the extent of myocardial infarction.
References
Sep 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·R R GormanF A Fitzpatrick
Jan 1, 1987·Journal of Cardiovascular Pharmacology·M E BrezinskiA M Lefer
Jul 1, 1985·Circulation Research·M BednarK M Mullane
Dec 1, 1985·American Heart Journal·M E BrezinskiA M Lefer
Apr 1, 1988·Circulation Research·K M Mullane, D Fornabaio
Aug 1, 1987·Cardiovascular Research·T KuzuyaM Tada
Jan 1, 1986·Annual Review of Pharmacology and Toxicology·B R Lucchesi, K M Mullane
Mar 1, 1985·Prostaglandins·E R McCluskeyP Needleman
Jan 1, 1981·Journal of Immunological Methods·R HjorthP Vretblad
Mar 1, 1984·Journal of Cardiovascular Pharmacology·V B Fiedler
Jul 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·E A HamF A Kuehl
Oct 1, 1983·Circulation·S FischerP C Weber
Dec 1, 1984·Journal of Molecular and Cellular Cardiology·M TadaS Murao
Aug 1, 1982·Prostaglandins·K M Mullane, S Moncada
Nov 12, 1982·Biochimica Et Biophysica Acta·T YoshimotoM Shiraishi
Oct 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J MacloufP Borgeat
May 1, 1983·Circulation·J L RomsonB R Lucchesi
Nov 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M A BoogaertsC F Moldow
Jan 1, 1980·Journal of Immunological Methods·W FalkE J Leonard
May 1, 1982·Circulation Research·D WyattJ M Downey
Dec 1, 1981·Circulation·M TadaH Abe
Citations
Feb 1, 1993·The International Journal of Biochemistry·T Siminiak, T Ozawa
Jul 1, 1996·Critical Reviews in Oncology/hematology·C Denzlinger
Nov 8, 2001·European Journal of Pharmacology·M LaM Perretti
May 10, 2000·Free Radical Biology & Medicine·H IwaseT Takatori
Nov 13, 2009·International Journal of Impotence Research·J García-CardosoA J López-Farré
Jul 25, 2007·Journal of Gastroenterology and Hepatology·Hongzhi XuJian X Zhang
Dec 1, 1994·The Journal of Clinical Investigation·N YamashitaM Tada
Mar 26, 2014·Nature Reviews. Cardiology·Nikolaos G Frangogiannis
Sep 1, 1994·The American Journal of the Medical Sciences·G Perez LasalaA K Markov
Jan 1, 1991·International Journal of Cardiology·S HoshidaT Kamada
Dec 31, 1993·International Journal of Cardiology·R KlimasH Wysocki
Jan 6, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Aiilyan K HoungGuy L Reed
Jun 27, 2021·Mechanisms of Ageing and Development·Vera PilsIngo Lämmermann
Sep 29, 2009·Cellular Signalling·Hyun-Jeong KwakHyun-Young Park